Prevalence, Detection, and Management of the Metabolic Syndrome in Patients with Acute Myocardial Infarction: Role of an Obesity-Centric Definition
Table 3
Characteristics of patients with and without NCEP MS.
Baseline Characteristic
NCEP MS ()
No. MS ()
value
Age
62.0 13.5
56.8 11.6
.035
Male
35 (67)
51 (93)
.001
Hypertension
37 (71)
14 (26)
.001
Smoking
15 (29)
27 (49)
.05
Diabetes mellitus
15 (29)
5 (9)
NS
Family history
15 (29)
19 (35)
NS
Dyslipidaemia
25 (46)
18 (33)
NS
New IFG
29 (59)
13 (24)
.001
Waist Circumference
107.2 15.3
94.1 16.2
.001
Height
1.67 0.12
1.68 0.12
NS
Hip
104.4 19.3
98.0 15.1
.062
Weight
87.5 19.9
77.9 13.8
.005
BMI
31.3 6.3
28.1 9.8
.056
Waist:Hip
1.2 1.4
1.0 0.2
NS
Systolic BP
114.0 16.9
111.6 13.3
NS
Diastolic BP
66.4 10.8
67.3 8.2
NS
Proximal LAD Disease
26 (52)
29 (53)
NS
Extent CAD
NS
1 VD
15 (30)
17 (32)
2 VD
16 (32)
20 (37)
3 VD
19 (38)
17 (32)
Final TIMI 3 flow
45 (92)
47 (87)
.4
LVEF (%)
44.2 7.3
42.1 8.7
NS
DT
179.6 65.9
197.5 57.1
NS
5.4 1.6
6.3 1.9
.046
E to ratio
14.8 5.5
11.8 4.1
.014
Fasting Glucose
7.1 2.7
5.6 0.8
.001
TC
4.9 1.5
4.4 1.0
.082
HDL
0.94 0.29
1.06 0.27
.037
LDL
3.1 1.3
2.8 0.8
NS
Trig
1.8 0.8
1.2 0.8
.001
Data are presented mean SD or (%). BMI: body mass index; CAD: coronary artery disease; DT: deceleration time; HDL: high-density lipoprotein; IFG: impaired fasting glucose; LAD: left anterior descending artery; LDL: low-density lipoprotein; LVEF: left ventricular ejection fraction; TC: total cholesterol; VD: vessels diseased.
